Composition for treating degenerative disease

Abstract

The invention relates to a composition for treating a degenerative disease. For solving the technical problems that an existing medicament can not reverse pathological changes of the degenerative disease and the treatment effect is not ideal, the adopted technical scheme is that the composition comprises royal jelly acid or a royal jelly acid derivative and ginkgo leaves in the ratio according to parts by weight of (0.1-10): (1-100). The composition has the technical effects that the royal jelly acid or the royal jelly acid derivative, gamma-aminobutyric acid or a gamma-aminobutyric acid derivative and the ginkgo leaves can play respective roles and simultaneously realize synergy, thereby significantly increasing the overall functions, effectively improving lipid metabolism caused by organism deterioration of old people, making up for defects of insufficient secretion of in-vivo synthesis, increasing brain blood supply, achieving the effects of effectively treating and delaying the progress of the degenerative disease, improving memory and cognitive dysfunction of a patient and greatly improving the quality of life of the patient with the degenerative disease (P<0.01).

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical products, and relates to a composition, in particular to a composition for treating degenerative diseases. Background technique [0002] A degenerative disease is a disease state in which cells and neurons of the brain and spinal cord are lost. The brain and spinal cord are made up of neurons that have different functions, such as controlling movement, processing sensory information, and making decisions. Cells in the brain and spinal cord generally do not regenerate, so excessive damage can be devastating and irreversible. Degenerative diseases are caused by the loss of neurons or their myelin sheath, which worsens over time, leading to dysfunction. Degenerative diseases include Alzheimer's disease (AD), amyotrophic lateral sclerosis, Parkinson's disease, cerebellar atrophy, Huntington's disease, Creutzfeldt-Jakob disease, multiple sclerosis, etc. Among them, Alzheimer's disease Alzheim...

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to solve the technical problem that existing drugs cannot reverse the pathological changes of degenerative diseases, and the therapeutic effect is not ideal. In order to solve this problem, we have designed a composition for treating degenerative diseases, which can significantly increase Its overall function can improve the lipid metabolism caused by body degeneration in the elderly, make up for the deficiency of synthesis and secretion in the body, effectively reverse the pathological changes of degenerative diseases, achieve treatment and delay the progress of degenerative diseases, and improve memory and cognitive dysfunction of patients It can improve cognitive functions such as attention and short-term memory, significantly improve the symptoms of patients with degenerative diseases, and greatly improve the quality of life of patients (P<0.01)

Images